http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3846747-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_459a1eaedadcb02b9cb51886d6d6fc6c |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2220-0016 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00781 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M27-00 |
| filingDate | 2019-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba8a40ad70905ca5b35a7eb47b694587 |
| publicationDate | 2021-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-3846747-A1 |
| titleOfInvention | Ocular device for treating glaucoma and related minimally invasive glaucoma surgery method |
| abstract | A bypass device can be implanted into a body tissue to provide fluid channels through the body tissue. The bypass device includes an open tubular base, and a plurality of pronged features attached to the open tubular base, the pronged features being reconfigurable from a first position to a second position. In the first position the pronged features extend longitudinally along a plane of the open tubular base, and the pronged features are reconfigurable to the second position by flexing the pronged features relative to the tubular base, such that in the second position the pronged features are configured for insertion through the body tissue. The pronged features may be configured as opposing arrow-shaped tangs that are flexed to form tent structures that are insertable through the body tissue. The bypass device may be used in a minimally invasive glaucoma surgery (MIGS) for treating glaucoma to define fluid flow channels that permit aqueous humor to pass through the trabecular meshwork and into Schlemm's canal. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11596550-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11737920-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11291585-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11766355-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11517477-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11529258-B2 |
| priorityDate | 2018-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5479131 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426095025 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945 |
Total number of triples: 23.